Collplant Biotechnologies Ltd
Biotechnology
Healthcare
CLGN
11.84 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
2.57
52 week high
5.42
high
2.58
52 week low
0.00
low
2.54
growth
-44.69 %
previous Close
2.49
P/E ratio
market cap
34.46 M
div yield
0
usd
Jun 2025
qoq
revenue
179 K
-91.29 %
net incoming
-3.35 M
-130.51 %
eps
0.00 %
276.92 %
eps surprise
264.29 %
net profit margin
-1869.83 %
-1799.00 %
operating incoming
-3.18 M
-92.84 %
net change in cash
727 K
161.93 %
cash on hand
11.71 M
9.05 %
cost of revenue
415 K
120.74 %
top top